Cyberattack Alert - Severe WARNINGS & CAUTIONS to All Members
NASDAQ 7,336.38 53.91 (+0.55%) DJIA 26,071.72 53.91 (+0.2%) S&P 500 2,810.30 12.27 (+0.43%) 19/01/2018 16:59

Teva - Aggressive Cuts Provide Relief

16/12/2017 18:04

In early October I looked at the prospects for Teva (TEVA) in an article titled, ¨Copaxone competition comes at the worst time¨. Shares were under pressure following the launch of a competing drug by Mylan (MYL) in a move which could cut operating earnings by $1.3 billion a year.

The timing of this news has been very unfortunate as Teva has already been under a lot of pressure after the acquisition of the generics business from Allergan backfired, and put a lot of (financial) pressure on the company. The company continues

Read more ...

More News

Adobe: Strong Finish To 2017

16/12/2017 15:41

There's a reason Adobe (NASDAQ: ADBE ) is consistently trending toward all-time highs: the ne...

An 11% Yield, With No K-1, On Qualified Dividends, From A Solid LP

16/12/2017 16:02

Trying to find high-yield income without the hassle of a K-1 at tax time? Maybe you should tak...

It's A Mad, Mad, Mad, Mad World

16/12/2017 16:35

I'm reasonably sure this has been mentioned by someone writing on this platform, and if it has...

Terms and Conditions | Privacy Statement is an educational platform. We DO NOT deal with securities and receive any financial benefits from Financial Products & Service Providers.